I think you would be astounded by the size of the TAVR market even when it was restricted older population. Edwards Life Science is able to get to a market cap of 40B USD on TAVR alone bu all accounts, our tissue is far superior and we have SAVR with an outstanding 1st patient outcome. Market like you is very cynical but I think the market is wrong.
I think you would be astounded by the size of the TAVR market...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.30 |
Change
0.300(1.67%) |
Mkt cap ! $351.7M | |||
| Open | High | Low | Value | Volume |
| $18.25 | $18.30 | $18.01 | $12.33K | 679 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.30 | 247 | 2 |
View Market Depth
| Last trade - 14.56pm 04/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |